Skip to main content
. 2021 Feb 2;5(3):364–370. doi: 10.1002/jgh3.12502

Table 3.

Adverse events during ustekinumab treatment

Adverse event Patients (n) Discontinued treatment (n of patients)
Infections
Fever 2 No
Herpes simplex infection 1 No
Pneumonia 1 No
Crohn's‐related
Subocclusion 3 Yes (2)
Perianal disease 2 No
Other
Anemia 1 No
Asthma 1 No
Reduction of visual acuity 1 Yes (1)
Skin reactions 2 No
Abdominal pain and weight loss 1 No
Arthralgia 1 No
Alopecia 1 No
Lymphadenopathy 1 No
Nephrolithiasis 1 No
Edema of the legs 1 No
Abortion 1 No